Ponmalar R, Manickam R, Saminathan S, Ganesh KM, Raman A, Godson HF. Evaluation of optically stimulated luminescence dosimeter for exit dose in vivo dosimetry in radiation therapy. J Cancer Res Ther. 2018 Oct-Dec;14(6):1341-1349. doi: 10.4103/0973-1482.191066. PMID: 30488854. Link

George S, Ponmalar YR, Godson HF, Kumar AS, Ravindran BP. Influence of Jaw Setting in the Determination of Stereotactic Small-Field Output Factors with Different Detectors. J Med Phys. 2022 Jan-Mar;47(1):65-72. doi: 10.4103/jmp.jmp_111_21. Epub 2022 Mar 31. PMID: 35548030; PMCID: PMC9084590.

Kumar S, Singh RR, Godson HF, Ponmalar R, Ravindran P, Sharma SD, John S. In-vivo dose measurements with MOSFET dosimeters during MV portal imaging. Rep Pract Oncol Radiother. 2021 Feb 25;26(1):93-100. do:10.5603/RPOR.a2021.0016

George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, Korula A, Lakshmi KM, Aboobacker FN, Kulkarni U, Godson HF, Raj JS, Abraham A, Backianathan S, Mathews V. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study. Clin Transplant. 2023 May 5:e15010. doi: 10.1111/ctr.15010. Epub ahead of print. PMID: 37144852.

Chakraborty S, Chatterjee S, Chakraborty S, Backianathan S, Lal P, Gupta S, Ahmed R, Misra S, Solomon P, Balakrishan R, Bhushal S, Guha D, Maria Das KJ, Mahata A, Mandal S, Kumari A, Finlay Godson H, Ganguly S, Kumari A, Shamsudden C, Dinesh M, Dey D, Chatterjee S. HYPORT Adjuvant Acute toxicity and patient dosimetry quality assurance results- Interim Analysis. Radiother Oncol. 2022 Jul 8:S0167-8140(22)04189-5. doi: 10.1016/j.radonc.2022.07.003. Epub ahead of print. PMID: 35817323.

Chakraborty S, Chatterjee S; Hyport Adjuvant Author Group Hyport Adjuvant Author Group. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis. Radiother Oncol. 2022 Sep;174:59-68. doi: 10.1016/j.radonc.2022.07.003. Epub 2022 Jul 9. PMID: 35817323.

Ponmalar R, Manickam R, Saminathan S, Ganesh KM, Raman A, Godson HF. Evaluation of optically stimulated luminescence dosimeter for exit dose in vivo dosimetry in radiation therapy. J Cancer Res Ther. 2018 Oct-Dec;14(6):1341-1349. doi: 10.4103/0973-1482.191066. PMID: 30488854. Link

George S, Ponmalar YR, Godson HF, Kumar AS, Ravindran BP. Influence of Jaw Setting in the Determination of Stereotactic Small-Field Output Factors with Different Detectors. J Med Phys. 2022 Jan-Mar;47(1):65-72. doi: 10.4103/jmp.jmp_111_21. Epub 2022 Mar 31. PMID: 35548030; PMCID: PMC9084590.

Kumar S, Singh RR, Godson HF, Ponmalar R, Ravindran P, Sharma SD, John S. In-vivo dose measurements with MOSFET dosimeters during MV portal imaging. Rep Pract Oncol Radiother. 2021 Feb 25;26(1):93-100. do:10.5603/RPOR.a2021.0016

George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, Korula A, Lakshmi KM, Aboobacker FN, Kulkarni U, Godson HF, Raj JS, Abraham A, Backianathan S, Mathews V. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study. Clin Transplant. 2023 May 5:e15010. doi: 10.1111/ctr.15010. Epub ahead of print. PMID: 37144852.

Chakraborty S, Chatterjee S, Chakraborty S, Backianathan S, Lal P, Gupta S, Ahmed R, Misra S, Solomon P, Balakrishan R, Bhushal S, Guha D, Maria Das KJ, Mahata A, Mandal S, Kumari A, Finlay Godson H, Ganguly S, Kumari A, Shamsudden C, Dinesh M, Dey D, Chatterjee S. HYPORT Adjuvant Acute toxicity and patient dosimetry quality assurance results- Interim Analysis. Radiother Oncol. 2022 Jul 8:S0167-8140(22)04189-5. doi: 10.1016/j.radonc.2022.07.003. Epub ahead of print. PMID: 35817323.

Chakraborty S, Chatterjee S; Hyport Adjuvant Author Group Hyport Adjuvant Author Group. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis. Radiother Oncol. 2022 Sep;174:59-68. doi: 10.1016/j.radonc.2022.07.003. Epub 2022 Jul 9. PMID: 35817323.

Ganesh S, Jasper A, Backianathan S, Moorthy RK, Balakrishnan R, Sebastian P, Moses V, Godson HF, Keshava SN, Rajshekhar V. Correlation Between Post-Radiosurgery Perinidal Hyperintensity and AVM Obliteration Following LINAC-Based Stereotactic Radiosurgery. World Neurosurg. 2023 Oct;178:e189-e201. doi: 10.1016/j.wneu.2023.07.032. Epub 2023 Jul 15. PMID: 37454908.

Joseph J, Raju KP, Jonathan GE, B R, Ganesh S, S P, Godson HF. Hypofractionated stereotactic radiotherapy in Spetzler Martin grades 4 and 5 arteriovenous malformations in the pediatric population: Is it a viable alternative? Childs Nerv Syst. 2023 Dec 10. doi: 10.1007/s00381-023-06244-0. Epub ahead of print. PMID: 38071636. Link

Varghese AJ, Gouthamchand V, Sasidharan BK, Wee L, Sidhique SK, Rao JP, Dekker A, Hoebers F, Devakumar D, Irodi A, Balasingh TP, Godson HF, Joel T, Mathew M, Gunasingam Isiah R, Pavamani SP, Thomas HMT. Multi-centre radiomics for prediction of recurrence following radical radiotherapy for head and neck cancers: Consequences of feature selection, machine learning classifiers and batch-effect harmonization. Phys Imaging Radiat Oncol. 2023 May 16;26:100450. doi: 10.1016/j.phro.2023.100450. PMID: 37260438; PMCID: PMC10227455.

Godson HF, Raj JS, Sebastian P, Ponmalar RY, Babu ES, Paul I, Krishna R, Backianathan S, George B, Ravindran PB, Balakrishnan R. Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center. Strahlenther Onkol. 2023 Oct;199(10):922-935. doi: 10.1007/s00066-023-02100-x. Epub 2023 Jun 6. PMID: 37278833.